Metabolic and Performance Effects of Yerba Mate on Well-trained Cyclists.
- 2018-04-01
- Medicine and science in sports and exercise 50(4)
- Jose L Areta
- Ingvild Austarheim
- Helle Wangensteen
- Carlo Capelli
- PubMed: 29117073
- DOI: 10.1249/mss.0000000000001482
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Sample size
- n = 9
- Population
- 11 well-trained male cyclists
- Methods
- Double-blind crossover design, 5 g YM or placebo (maltodextrin) daily for 5 d and 1 h before experimental trials
- Blinding
- Double-blind
- Duration
- 5 days
- Funding
- Unclear
Introduction
Yerba Mate (YM) is a South American plant, rich in polyphenols, saponins, and xanthines, of growing scientific interest because of its metabolic effects. YM has been shown to increase fat utilization during exercise in untrained humans, but its effects on well-trained individuals during exercise are unknown.Methods
We characterized metabolic and physical performance effects of YM in 11 well-trained male cyclists. In a double-blind crossover design, participants ingested 5 g of YM or placebo (PL; maltodextrin) daily for 5 d and 1 h before experimental trials.Results
Ergometer-based tests included a submaximal step test (SST) at 30%-80% of V˙O2max (6 × 5-min stages), followed by a cycloergometer-based time trial (TT) test to complete mechanical work (~30 min; n = 9). Before and during tests, blood and respiratory gas samples were collected. YM increased resting plasma adrenaline concentration (P = 0.002), and fat utilization by 23% at 30%-50% V˙O2max versus PL (Glass effect sizes (ES) ± 95% confidence interval (CI), 0.8 ± 0.55) correlating strongly with post-SST plasma (glycerol; r = 0.758). Treatment effects on rates of perceived exertion, heart rate, and gross efficiency were unclear during SST. Respiratory exchange ratio during TT indicated carbohydrate dependence and did not differ between treatments (PL, 0.95 ± 0.03 (SD); YM, 0.95 ± 0.02). TT performance showed a small (ES = 0.38 ± 0.33) but significant (P = 0.0278) improvement with YM (PL, 30.1 ± 1.8 min (SD); YM, 29.4 ± 1.4 min; 2.2% ± 2% (95% CI)), with an average increase of 7-W power output (ES = 0.2 ± 0.19; P = 0.0418; 2.3% ± 2% (95% CI)) and 2.8% V˙O2 (P = 0.019). Pacing displayed lower power output after 30% of total TT workload in PL vs YM.Conclusions
YM increased fat utilization during submaximal exercise and improved TT performance, but performance-enhancement effect was unrelated to measures of substrate metabolism during maximal exercise.Research Insights
Treatment effects on... gross efficiency were unclear during SST
- Effect
- Neutral
- Effect size
- Small
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
Pacing displayed lower power output after 30% of total TT workload in PL vs YM
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
YM increased fat utilization by 23% at 30%-50% V˙O2max versus PL (Glass effect sizes (ES) ± 95% confidence interval (CI), 0.8 ± 0.55)
- Effect
- Beneficial
- Effect size
- Large
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
2.8% V˙O2 (P = 0.019)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
average increase of 7-W power output (ES = 0.2 ± 0.19; P = 0.0418; 2.3% ± 2% (95% CI))
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
Treatment effects on... heart rate... were unclear during SST
- Effect
- Neutral
- Effect size
- Small
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
Treatment effects on rates of perceived exertion... were unclear during SST
- Effect
- Neutral
- Effect size
- Small
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
Respiratory exchange ratio during TT indicated carbohydrate dependence and did not differ between treatments (PL, 0.95 ± 0.03 (SD); YM, 0.95 ± 0.02)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 5 g/day for 5 days and 1 h before experimental trials
TT performance showed a small (ES = 0.38 ± 0.33) but significant (P = 0.0278) improvement with YM (PL, 30.1 ± 1.8 min (SD); YM, 29.4 ± 1.4 min; 2.2% ± 2% (95% CI))
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 5 g/day for 5 days and 1 h before experimental trials